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Abstract 
     There has been an increase in the preventable communicable disease known as Pertussis as 
the result of waning immunity in adolescents and adults. Waning immunity is the loss of 
protective antibodies over a period of time.   Despite the availability of a new immunization in 
2005, adult immunization rates do not meet Centers for Disease Control (CDC) Healthy People 
2020 goal.  Adult immunizations remain a challenge.  Preventive healthcare is the keystone to 
providing routine vaccination coverage. It is usually the point of entry into the health care 
system.   
    The theoretical model used was the Precaution Adoption Model, which allowed the provider 
the opportunity to provide immediate information to the patient at the time of the visit.  This  
provided the patient time to make an educated decision at the time of the office visit to receive or 
decline the Tdap immunization.   
    The purpose of this project was to implement a process to increase the rate of pertussis 
immunity with the use of tetanus toxoid, diphtheria toxoid and pertussis immunization (Tdap) to 
the patients in our practice.   
     All patients 19 years of age and over who had a scheduled office visits in our practice, with 
one of our three providers were provided the questionnaire to complete on immunization status.  
We offered the immunization to both genders 19 years of age and older.  Those patients seen by 
a provider daily 19 to 64 years of age were identified as study participants.   
     With the use of questionnaire, it was found that 21% to 40% of patients seen during the 8 
weeks of project had received their Tdap immunization prior to their office visit.  Once the 
provider offered and if indicated explained the importance of the Tdap immunization an 
additional 33% to 49% patients were provided the immunization.  Though provided the 
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information and recommendation 25% to 35% of those patients seen during their office visit 
declined the immunization.  The visits during the eight week of project increased the rate of 
Tdap immunizations from 61% to 77% which fell short of the CDC’s goal of 90%, but was 
found to have a significant increase with the questionnaire.   
     The questionnaire used was well received by providers, staff and patients and did not increase 
in time requirements for the patient intake process.  There were two limitations to administer the 
Tdap immunization in our office. The first is insurance carriers.  Medicaid does not allow us to 
administer any immunizations in the office, so those patients with that specific insurance were 
unable to receive, even they wanted it.  Next is those patients who rely on Medicare for payment, 
Medicare will not cover the Tdap administration for prevention.  The second limitation is those 
patients who have no insurance and are self-pay refused to take due to cost.  At present there is 
no program in our company to assist patients with financial needs to receive a reduction in cost.   
This Capstone experience concluded that the primary care office and the patient’s office visit is 
an effective site for implementing immunization administration of Tdap to increase the public 
health issue of declining immunity of pertussis and the indication for immunizations.   
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Increasing the Rate of Pertussis Immunity Using the Tdap Immunization in Primary Care for 
Patients 19 to 64 Years of Age 
      Public health initiatives have had great success in the implementation of immunization 
programs leading to the eradication of communicable diseases with the use of vaccination such 
as smallpox, polio and diphtheria (CDC, 2009).  Childhood mortality has been reduced by 99% 
for those patients over the age of twelve months, who have been immunized at scheduled 
intervals established by the CDC.  Since 1976 the number of cases of pertussis has risen with the 
greatest increase seen in children and adults due to waning of immunity and increased awareness 
of the disease in these age groups.  In the adult population there continues to be to an estimated 
25,000 cases per year of pertussis as a result of waned immunity (Cortese, et al, 2007).  Waning 
of immunity is the gradual loss of immunity over time.  Waning of pertussis immunity in adults 
increases the risk to infants of Pertussis when exposed to adults with an active case of Pertussis.  
Infants too young to have received the first three doses of pertussis-containing vaccine are at the 
biggest risk for illness related to exposure to circulating pertussis (Plotkin et al., 2008).  Evidence 
based information indicates that infants are at greatest risk for pertussis infection from family 
members and close contacts who are infected and have the potential of transmission of infection 
to the infant (Gerbie & Tan, 2009).  
Background/Significance 
     Prior to widespread use of whole-cell pertussis vaccine, there were as many as 270,000 cases 
of pertussis reported each year in the United States, with ten thousand deaths (Cherry et al., 
1988).   The first recorded description of an outbreak of pertussis is that of Guillamume De 
Baillou during the summer of 1578 in Paris, France. The causative bacteria was not identified 
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until 1906 (Atkinson et al., 2011) with the first pertussis vaccine made available in the early 
1940’s (CDC, 2009).   Bordetella pertussis is solely as a human pathogen.  It is the primary cause 
of clinical whooping cough and readily transmitted by aerosolized droplets (Yeh & Mink, 2012).   
     With the introduction of whole cell pertussis vaccine administered to children in the mid 
twentieth century there was a decrease in the occurrence of pertussis.  The lowest annual 
infection rate was in 1976 when just 1000 cases were reported (ACIP, 1997).   With a decrease in 
American adults not getting vaccines updated they need to prevent developing and spreading 
preventable diseases, 25,827 cases of pertussis climbed in 2004, the highest since 1959 
(Kessinger, et al, 2006). 
       Pertussis is associated with significant morbidity and mortality, specifically among the very 
young and very old.  Ninety percent of pertussis related deaths affect infants under the age of six 
months (Mikelova et al, 2003).  The new recommendation from the CDC is to immunize adults 
19 to 64 years of age who come in close contact with infants under twelve months with pertussis 
in the form of Tdap immunization.  Household members are responsible for up to 83% of the 
pertussis bacteria exposure to infants under twelve months (Wendelboe et al., 2007).   
     In 2005, the CDC recommended that individuals between 19 to 64 years of age be immunized 
once with Tdap.  Despite the recommendation the CDC’s October 15, 2010 Morbidity and 
Mortality Weekly Report revealed that, in 2008 only 5.9% of individuals 19 to 64 years of age 
had received the Tdap immunization.  In addition only 5% of adults with infants had been 
vaccinated with the Tdap immunization (CDC, 2010).  The American Nurses Association (ANA) 
(Appendix A) proposed a letter to receive support from other health organizations to increase the 
rate of Tdap immunizations nationwide with many of the leading medical organizations signing 
the letter to commit to immunizing.   
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     The literature search for this project failed to uncover any report of the percentage of health 
care providers who routinely offer the Tdap vaccine during office visits. However, despite the 
availability of Tdap since 2005 in the United States, the vaccine remains underutilized (Kirchner, 
2011).  The reasons for underutilization of the vaccine in primary care include the cost of 
purchasing, storing, administration and documentation required of immunizations (Davis et al., 
2003). In a survey of obstetricians, who are a direct link to adults in contact or soon to be in 
contact with infants, 81% of the 183 obstetricians, reported that primary care providers failed to 
administer the Tdap immunization when patient was seen in their office (Clark et al., 2006).  
Problem Statement 
     Pertussis is a highly contagious respiratory infection.  Public health data indicates a 
significant increase in cases during the last two decades. The current standard of care for 
immunization administration for adults who are 19 to 64 years old should receive a 1-time dose 
of Tdap in place of Tetanus-diphtheria (Td) booster that is recommended to receive every 10 
years (Appendix A).  There is no need to wait till the next Td is scheduled it is recommended 
that the Tdap be given at next office visit with a health care provider.  Pregnant women who 
have not been preciously vaccinated with Tdap should get one dose of during the late second to 
third trimester or immediately postpartum.  By getting Tdap during pregnancy, maternal 
pertussis antibodies transfer to the newborn, thus proving protection against pertussis in early 
infancy (CDC, 2012).  Without the implementation of the adult immunization of Tdap, pertussis 
is expected to double in the next twenty years (Wendelboe, et al, 2005).   
     There are an estimated 25,000 reported cases of Pertussis annually in the United States caused 
by exposure to the contagion to individuals without sufficient immunity (Cortese et al., 2007).  A 
significant increase in cases has been observed since the early 2000’s.  Adolescents and adults 
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are a primary source of infection to infants under the age of twelve months who have not 
completed the immunization series (Zastrow, 2011).  Infants and the elderly are at highest risk 
for pertussis complications and death (Biscard et al., 2004).   
     The Advisory Committee on Immunization Practices (ACIP) recommends the routine use of a 
single dose of Tdap for 19 to 64 year olds to prevent transmission of pertussis to others 
(Kretsinger et al., 2006). The CDC added in 2010 that those individuals 65 years of age and older 
should also receive the Tdap immunization. Medicare does not pay for the Tdap immunization 
and will only pay for tetanus diphtheria if there is evidence of a puncture wound, even though the 
CDC recommends this population to be immunized.  Health care workers are called to 
implement immunization recommendations from ACIP to protect themselves, their patients, and 
the community from pertussis.  This project was designed to increase the rate of immunization of 
pertussis with the use of the Tdap immunization in primary care practices.  There is a lack of 
documented information to identify the percentage of health care providers who educate and 
provide Tdap immunizations with their patients during an office visit. Recent discussion with 
Nathan Grossman, MD Medical Director of the Marion County Health Department indicated that 
there is no statistical documentation related to the percentage of Tdap immunizations given in 
primary care offices in Marion County.   
     The National Immunization Survey (NIS, the Behavioral Risk Factor Surveillance Survey 
(BRFSS), and the National Health Interview Survey (NHIS) have added Tdap coverage to their 
surveillance assessments of immunization status.  Since the Tdap vaccine for adults 19 to 64 
years of age has only recently been licensed in 2005, many facilities are currently just beginning 
to gather immunization information.  
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     Tracking and reminder system is difficult if the medical office does not have electronic 
medical records (EMR).  At present time our office does not have EMR. It is anticipated that we 
will go companywide in June of 2013, but until then a paper questionnaire was utilized with 
documentation on yellow patient information divider in each chart.  
      The waning of pertussis immunity in adults has increased over the past two decades and is 
expected to continue to increase.  The waning of pertussis immunity increases the risk of disease 
in non-immunized individuals especially infants under 12 months of age.   
Aims of Project 
     There continues to be an increase in cases of pertussis caused by a combination of exposure to 
the bacteria and a waning of immunity in adolescents and adults.  Primary care providers have 
the greatest opportunity to immunize these individuals during visit.  However, healthcare 
providers have limited time to assess the patient, address new findings and then address the 
concerns of the patient may not remember at that time to discuss updating the immunization of 
pertussis.  The evidence available has shown that there is a decrease in cases of pertussis when 
immunizations are introduced.   
      The aim of this research translation project was to standardize use of the Centers for Disease 
Control recommendation to immunize individuals between 19 and 64 years of age with the Tdap 
immunization without increasing time demands on the healthcare provider.  Application of the 
guidelines have increased the rate of immunization of the target population, but have not yet 
succeeded in attaining the goal of 90% of the population immunized against pertussis with the 
Tdap immunization.   
     The increase in pertussis rate during the past two decades is the result of waning immunity in 
adults 19 to 64 years of age with expected rate of pertussis to increase in the next two decades.  
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The increase in pertussis as the result of waning immunity causes a greater risk to those infants 
under the age of 12 months.   
Review of Literature 
Study Significance 
     Pertussis is a disease differentiated from other respiratory illnesses by the classic symptoms of 
severe coughing, which has a whooping characteristic, and post-intrusive vomiting, which can 
last for weeks (Atkinson, et al., 2011).  One of the most beneficial and cost effective prevention 
measures is the use of immunizations.  Pertussis once thought of as a childhood immunization is 
also used in combination with tetanus and diphtheria as a vaccination to provide immunization to 
those over the age of 19 years (Maciosek et al., 2006).   
     Pertussis, commonly known as whooping cough is an acute, communicable respiratory illness 
caused by the Bordetella bacterium.  It continues to be endemic in spite of childhood 
immunizations (Kretsinger et al., 2006).  Without immunizing adults over 19 years of age, it is 
expected that Pertussis cases will double in the next twenty years (Wendelboe et al., 2005).  
Pertussis immunizations were first provided in the 1940’s after the bacterium was identified in 
the early 20th century (Atkinson et al., 2011).  With the introduction and regular administration 
of the vaccination there was a decline in annual cases from 200,000 in the 1940’s to a low of 
1,010 cases in 1976 (Farizo et al., 1992).  In 2004 the CDC reported 7,008 cases of pertussis in 
adolescents and adults (Center for Disease Control, 2006).   
     Childhood immunizations account for a reduction in mortality rates of 99% from the 
communicable diseases that they are used for, however, pertussis continues to see an average of 
25,000 cases annually due to waning of immunity (McCullers, 2007).  Pertussis that affects 
adolescents and adults accounts for approximately 90 percent (Mikelova et al., 2003) of the 
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incidence and mortality among exposed infants less than four months of age who are without 
immunity to pertussis.  With increased awareness of waning immunity after ten years, 
adolescents and adults are thought to be the reservoir of the bacteria and the source of 
transmission to infants who have not completed the child pertussis immunization series (Lee, et 
al., 2005).   
     In 2005, the CDC, along with the ACIP, recommended immunization to pertussis in the form 
of Tdap to those 19 to 64 years of age (Spratling & Carmon, 2010).  In October 2010 the CDC, 
along with ACIP, added a single dose of Tdap for adults over 65 years of age to be immunized 
against pertussis (Centers for Disease Control, 2011). The United States Food and Drug 
Administration (FDA) have approved a booster vaccine to include adults 65 years of age and 
older (Lowes, 2011).  There is no well-defined cyclic relationship among humans, although there 
may be the possibility of an increase in summer and fall (Atkinson, et al., 2011).  The 
syndrome’s appearance can range from mild symptoms to the classic presentation (Vitek et al., 
2003). 
Causative Agent 
     The fastidious gram-negative coccobacillus Bordetella pertussis bacteria are transmitted from 
person to person from the respiratory tract in the form of aerosol droplets expelled during the act 
of coughing or sneezing.  It is estimated those who are not immune are exposed by infected 
contacts up to 90% of the time, and the individual’s home is the usual exposure environment 
(Murphy et al., 2008).  The incubation period once a person is exposed to the bacterium is seven 
to ten days but can range from six to twenty days (Duclos & Halperin, 2008). 
     There are three classic phases of pertussis, catarrhal, paroxysmal and convalescence (CDC, 
2011& Murphy et al., 2008).                                                                                                                                     
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 Pertussis in the catarrhal phase (initial) last two to three weeks and is highly                                            
communicable.  The insidious onset of symptoms is comparable to an illness of the 
respiratory tract which one would expect to observe watery nasal discharge, frequent 
cough, and sneezing and conjunctiva injection.  The cough is observed to be short, 
hacking and isolated, and can occur night and day.  Fever is not common in any phase of 
pertussis. If there is a fever an underlying infection should be suspected.   
  The next stage is paroxysmal. It is during this time of the symptoms that pertussis is 
suspected and tested for.  This phase lasts from two to six weeks and unlike the catarrhal 
phase has intermittent intense (paroxysms) that alternate with periods of normal 
respiratory rate (during which time they appear to be reasonably well).  Paroxysms 
present as spasms and coughing with post-tussive vomiting and inspirational whoop, thus 
resulting in the common name of whooping cough.  Infants and young children during 
this phase can become quite ill and even need hospitalization.  It is during this phase that 
testing should be initiated.   
 The third and final stage is convalescent.  This phase may last from two to six weeks, 
with gradual recovery, but symptoms may be present for up to six months.   
     The most common complication and the cause of most pertussis-related deaths is secondary 
bacterial pneumonia.  Infants under six months of age are at highest risk for acquiring these 
complications.  Data from 2000 indicates that pneumonia occurred in 5.2 percentages of all 
reported pertussis cases, and among 11.8 percentages of cases in infants under than six months of 
age (Halperin et al., 1999).  Most recent data from the years of 2004 to 2008 a total of 111 deaths 
were reported for the four year period.  Infants three months of age and younger accounted for 92 
(83%) of those deaths (Brooks & Clover, 2006). 
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     Healthcare workers add another dimension to those in direct contact with those individuals 
who are not immunized or whose immunity has waned over the years since the last 
immunization.  One hospital reported seventeen symptomatic cases of pertussis resulted from 
just a 24 hour exposure to an infant; pertussis was confirmed 16 days later.  When the 
investigation was completed there were 307 exposed cases among patients, family members and 
friends of the initial health care worker.  The direct and indirect costs borne by the hospital due 
to the nosocomial infection was $74,870 (Calugar et al., 2006).  
Economic Burden 
     The full economic burden of pertussis is limited due to the lack of reliable data if 
effectiveness of immunization. The direct costs of pertussis, varies with age and the severity of 
disease.  There are both direct and indirect costs that impacts society.  An uncomplicated case of 
disease cost around $135 but a complicated case requiring hospitalization can increase to $6337.  
The indirect costs are considerable when assessing the variables.  Parents may not be able to 
work when caring for a child who is sick which may require a long recuperation period which is 
estimated as much as 73% of the total cost of pertussis (Lee & Pichichero, 2000).   Since 
pertussis may present comparably to other cough and respiratory diseases, it may take up to two 
to three visits to the healthcare provider until a definitive diagnosis is identified (DeSerres et al., 
2000). 
     A literary search found limited studies assessing rates of pertussis administration with Tdap in 
out of hospital sites known as primary care and internal medicine offices.  These health care 
offices are responsible for the health of a large portion of the community’s population.  Programs 
have been established in hospitals and public health facilities to require the use of Tdap. In 
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schools legislation requires immunizations to be up to date throughout the student’s time in 
public schools and eventually entry into secondary education.   
Vaccination of Adults 
     Nationally, children have been provided immunizations since the first legislative efforts 
during the 1950’s with the polio vaccine (Engel, 2006). During the first administration of the 
polio vaccination every child was taken to designated immunization sites and received the 
vaccination which was in a sugar cube.  The federal government provides funding under 
legislation known as Vaccines for Children (VFC) entitlement program but there is no such 
program for adults.  As a result of the lack of financial assistance from federal mandated 
programs, health care provider’s not offering immunization services in private office and the cost 
of immunizations at the health department (Engel, 2006); there is limited access for those 
without insurance to receive the immunization. It is reported that the immunization rate of adults 
19 years and older range from 3 percent to 32 percent (CDC, 2011).  This is far below the CDC’s 
and Healthy People 2020 for 90 percent of those 19 years of age and older to be immunized with 
pertussis in the form of Tdap.   
Adult Immunization Practice 
     The first published standards for the administration of adult immunizations was in 1990, with 
the most current revision being in 2003 as the result of dramatically changing health care system.  
There is a shift toward managed care with changes in provider incentives and reimbursement for 
preventive health services.  The revised standards are a collaborative effort for more than 100 
people and 60 organizations (Poland et al., 2003). 
Table I:  Revised standards for adult immunization practices 
Standard Approach 
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Make vaccinations available 1. Adult vaccination services are readily 
available. 
2. Barriers to receiving vaccines are 
identified and minimized. 
3. Patient “out-of-pocket” vaccination 
costs are minimized. 
Assess patients’ vaccination status 1. Health care professionals routinely 
review the vaccination status of 
patients. 
2. Health care professionals assess for 
valid contraindications. 
Communicate effectively with patients 1. Patients are educated about risks and 
benefits of vaccination in easy-to-
understand language. 
Administer and document vaccinations 
properly 
1.  Written vaccination protocols are 
available at all locations were vaccines 
are administered. 
2. Persons who administer vaccines are 
properly trained. 
3. Healthcare professionals recommend 
simultaneous administration of 
indicated vaccine doses. 
4. Vaccination records for patients are 
accurate and easily accessible. 
5. All personal that have contact with 
patients are appropriately vaccinated. 
Implement strategies to improve vaccination 
rates. 
1. Systems are developed and used to 
remind patients and healthcare 
professionals when vaccinations are 
due and to recall patients who are 
overdue.   
2. Standing orders for vaccinations are 
employed. 
3. Regular assessments of vaccination 
coverage levels are conducted in a 
provider’s practice. 
Partner with the community 1.  Patient-oriented and community-based 
approaches are used to reach target 
populations.   
http://www.azdhs.gov/phs/immun/pdf/immunications/winter07/InsertA_Winter2007.pdf 
Theoretical Model 
     The Precaution Adoption Process Model (PAPM) offers seven distinct actions to move from 
being unaware of an issue to maintenance of a behavior (Weinstein & Sandman, 1992).  Each 
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distinct action provides a specific approach to meet the final objective of increasing the 
awareness of pertussis, thus increasing the rate of herd immunity and decreasing the incidence of 
pertussis and mortality rates of infants less than six months of age.   
     During the patient visit the health care provider provided education material and answered 
patient questions related to pertussis.  It was expected by the end of the office encounter that the 
patient understands the importance of receiving the immunizations and agrees to act upon the 
information and knowledge.    
 Stage I-Unaware of issue:  Patient was exposed to information regarding the 
immunization Tdap on closed circuit television in lobby of primary care office.  The 
patient was taken to the examination room and was provided written and verbal 
information regarding pertussis.   
 Stage II-Unengaged by issue:  Patient will be provided additional information regarding 
the transmission of pertussis and the increase effects on infants under twelve months old.   
 Stage III-undecided about acting:  It is upon the completion of stage I and II: the provider 
will ask if the patient has decided to receive the immunization today while at office. 
  Stage IV-Decided not to act:  Patient at this time with all information if they decide they 
do not want immunization at this time.  There will be documentation on chart of refusal 
 Stage V-Decided to Act:  The patient will now be provided with the required Vaccination 
Immunization Statement, patient will be asked to sign all information. 
 Stage VI- Acting:  At this time immunization will be administered. 
  Stage VII-Maintenance: The patient will be provided printed and verbal information 
regarding treatment of soreness or elevated temperature.  The patient will be given an 
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immunization card and phone number to call for treatment of possible side effects.  
Repeat Td in ten years.  
     The Precaution Adoption Process Model provides the health care provider to assess the 
patient he/she is seeing at an office visit regarding their knowledge of pertussis and the 
recommendations of the CDC.  The steps provide a quick guide for entry into discussion.  It is a 
quick assessment and can be obtained in less than 5 minutes which does not utilize a great deal 
of time at the office visit.   
Method 
     In 2005, the ACIP recommended that adults 19 to 64 years of age be immunized against 
pertussis in a single dose of pertussis in the form of a Tdap (Kretsinger, et al., 2006).  The target 
population for this project will be all adult patients age 19 to 64 years that are seen in Ocala II 
(OII) primary care office for a scheduled appointment with the provider at proposed site each 
day for two months.   
Project Site 
     The proposed site is one of seven offices associated with Hospital Corporation of America 
(HCA) located in central Florida.  The site for the purpose of this project will be done at OII.  
The community at large has a population of 331,298 from the 2010 census (Quickfacts, 2010).  
The county is comprised of 81.0 percent of white persons, 12.3 percent of black persons, 0.4 
percent of American Indian and Alaska native persons, 1.3% Asian persons, and 10.9% persons 
of Hispanic or Latino (United States Census Bureau, 2010).  The practice site that participated in 
the project has 70 percent white persons, 24 percent black persons, 5 percent Hispanics and 1 
percent all others.  The site takes most insurance coverage, except traditional Medicaid and 
couple of Medicare HMO’s.  The office case mix is composed of 50 percent Medicare, 40 
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percent commercial and 10 percent self-pay.  A convenience sample of all patients aged 19 to 64 
years of age at one site of a seven site company in Ocala, Florida with commercial insurance was 
used for this program to evaluate the outcome results of increasing the rate of pertussis 
immunization administration.  
     In 2005, the CDC recommended that individuals between the age of 19 to 64 years of age to 
be vaccinated against pertussis, tetanus and diphtheria.  Despite this recommendation, the CDC’s 
October 15 Morbidity and Mortality Weekly Report revealed that, in 2008 only 5.9% of 
individuals 19 to 64 years of age had received the Tdap immunization.  In addition only 5% of 
adults with infants had been vaccinated with the Tdap immunization (CDC, 2010). The 
American Nurses Association (Appendix A) proposed a letter to receive support from other 
health organizations to increase the rate of Tdap immunizations nationwide with many of the 
leading medical organizations signing the letter to commit to immunizing. 
     The ideal situation would have been to have a computerized electronic medical record. But at 
this time the company involved in this capstone project does not have access to medical records.  
The purpose of this project was to program a clinical practice guideline for Tdap administration 
into a decision support system connected to the patient’s hard copy chart.   
Patient Encounter 
     The patient received a questionnaire (Appendix B) at the time of check-in to check status of 
Tdap immunization, if patient was unable to read the questionnaire than a staff member assisted 
them with the questionnaire, but did not influence any of responses.  The medical assistant calls 
patient by salutation and last name from the waiting room.  The medical assistant escorts the 
patient back to the examination room and during the triage encounter; an assessment of 
immunization status was completed.  If the patient did not have a Tdap immunization since 2005 
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they were provided a Vaccination Information Sheet (VIS) (Appendix C).  The CDC requires 
that if a vaccine is to be given that the patient is provided information on the risks and benefits of 
the vaccination before administration.  As a result the CDC has standardized in formation in the 
form of the VIS (Appendix C).  These forms can be easily accessible at the CDC website 
(www.cdc.gov/vaccines/pubs/vis/vis-downloads.htm) or at the Immunization Actions Coalition 
website (www.immunize.org).  The VIS forms are written at a 5th grade level and are in multi-
languages.   
     The provider then provided additional information and explanation with time allotted to 
answer any questions.  The healthcare provider then evaluated if there was any contraindications 
that would prevent the patient from receiving the Tdap immunization at this appointment.  If 
patient is unable to receive due to contraindication, but would be eligible for it later.  The 
questionnaire is to be placed in front of the patient’s chart until next office visit.  If the patient 
has had a Tdap vaccination since 2005, documentation of this information was entered into 
patient profile form.  The patient with evidence of not receiving the Tdap vaccination who spoke 
with their healthcare provider and agreed to receive the immunization, the healthcare provider 
provided an order to administer during the visit.   
     The immunization was administered, documentation was completed on the patient was given 
an immunization card.  The medical assistant entered the data into Florida Shots, which is the 
required data base for all immunizations in Florida.  The healthcare provider finalized the visit 
and discharged the patient home.  Once the company implements EMR, a program will be 
included for immunizations, along with a printed out immunization record for the patient upon 
discharge.  
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       The following algorithm allowed the staff to review the process of intake for immunizations.  
It will be used as part of the orientation process for all new employees.  The staff was provided a 
copy of algorithm and it was placed in the clinic’s policy and procedure book.  It will be 
reviewed on a yearly basis with the office manager, medical director and nurse practitioner for 
any changes in association with the CDC and ACIP.   
Figure I: Case diagram for Adult Immunizations in Primary Care Practice 
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Organizational Analysis of Project Site 
     The proposed site is one of the seven primary care sites within the national organization 
located in central Florida.  There are two hospitals available to patients owned by the same 
national organization.  There are seven primary care sites, two hospitals, and twenty-eight 
providers.  The healthcare providers associated with the company consist of two doctors of 
osteopathic medicine, two internal medicine, one hospitalist, fifteen medical doctors, eight 
advance practice nurses (arnp), with two holding a doctorate of nursing practice.  The 
corporation has a medical director, there are regional medical directors, and each office has a 
medical director.  Each primary care office is encouraged to maintain their individual practice 
styles.  There are four practice managers who are responsible for the offices in our local group 
(Appendix D).  The providers who work at OII which is the targets site, is one internal medicine 
physician with a PhD., one medical physician, and one nurse practitioner a doctoral candidate in 
nursing practice from University of Massachusetts, Amherst.   
     The national corporation that is responsible for our operating budget has allowed each 
primary site to operate independently.  Each site is responsible for practice policies, management 
of staff for growth and development.   The practice (Ocala II) site has a medical director and an 
internal medicine physician who are considered the stake holders and a nurse practitioner.  
     The medical director of the project site is responsible for this individual office site; he 
graduated from medical school 23 years ago and did his residency in family practice.  He has 
served as medical director for ten years. He also serves on the board for the technical school, 
Patient checks out at 
completion of appointment 
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provides health care at a local extended care facility, is a preceptor for University of Florida 
medical students and sees an average of 28 patients per day.   
     The other stakeholder is an internal medicine physician who graduated 35 years ago from 
medical school and has a second degree as a PhD of biology.  He also sees patients in six nursing 
homes weekly and serves as medical director for three of the long term care facilities that he 
attends.  He currently sees an average of 23 patients per day.   
     The ARNP is certified in family practice and pain management works with both physicians 
and maintains her own practice.  She has been a nurse practitioner for 16 years and has practiced 
as a nurse for 42 years.  She is a preceptor with the University of Florida for nurse practitioners 
and speaks on health care issues in the community.  She sees an average of 25 patients per day.   
     The office manager is responsible for two of the seven offices.  There are 15 support staff 
members for OII.  Four staff members in the front office are responsible for check in, insurance 
verification, prior authorizations, and check out.  Three staff members are responsible for 
medical records, and two staff members answer phones, schedule appointments and take 
messages.  The internal medicine physician has a registered nurse and medical assistant; the 
other two providers have two medical assistants each (Appendix E).     
      The study participants were the patients of Ocala II’s practice who were seen by one of the 
three providers at scheduled appointments daily Monday thru Friday.  The participants seeing 
one of the three providers for a scheduled appointment were provided a questionnaire (Appendix 
B) later discussed in this paper.  Once the age of the patient was determined those patients 65 
years and older were excused from the study.  Those patients 65 years of age and older can 
receive immunization as recommended by the CDC in October of 2010 if they come in contact 
with infants under 12 months of age.  Unfortunately Medicare insurance and Medicare HMO’s 
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will not cover the cost of the immunization.  These patients will be offered the immunization, but 
they will have to pay for it.  It is important to note that those patients 65 years of age and older 
are not part of the targeted population, but if they desire the Tdap immunization they will be 
provided it.   
Resources/Constraints/Facilitators/Implementation-at Project Site 
     The project site has supplies ordered every two weeks, and the supply of immunizations has 
been maintained to meet the needs of the patients without interruption of supplies.  There is 
unlimited accessibility to printer and printer supplies. There was support from management, 
physicians and clinical staff for this project.  A letter of support from the medical director 
(Appendix F) related to the importance of this timely capstone is included.   
Protocol for Project and Intervention Tailoring 
     With the identification of the need for improved administration of pertussis, there is evidence 
of need to increase the rate of immunization at the patients scheduled office visit with their 
primary care provider.  With each patient who was 19 years and older that had a scheduled visit 
with their health care provider were provided a short questionnaire to answer (Appendix B) to 
assess their immunization status.  If the patient has not been immunized since 2005, and there are 
no contraindications the provider proceeded to place the patient into the sample.  The patient was 
provided time to ask questions at the time of the visit.  If the patient consented, then Tdap was 
administered.  The Vaccination Immunization Statement (Appendix C) will be provided.  Upon 
administration a shot card will be provided and information will be entered into Florida Shots, 
the required state run immunization registry.   
Project Design and Feasibility 
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     The design of this project was to examine the effectiveness of providing a reminder system on 
the chart prior to the provider seeing the patient at site (Ocala II) and providing education and 
information regarding pertussis and the immunization Tdap. The staff in the project site was 
provided a training session.  The training session reviewed the tools to be used with rationale for   
project. The use of a power point presentation was used to provide the staff the ability to return 
to the training session if needed (Appendix G).  During the training session the staff was 
provided time to familiarize them with the questionnaire, required paperwork and documentation 
for administrating the Tdap immunization.  Staff members who participated in this project 
consisted of check-in, medical assistants, Registered Nurse and providers, which was a total of 7 
who were in direct patient care.   
     The completed training instruction session for the staff signaled the initiation of the project.   
The program is feasible and approved by the stake holders, there are enough supplies, and the 
medical director was in agreement that the administration of the pertussis vaccine in the form of 
Tdap was done during the office visit without a negative effect on the flow in the office.  
     Check in staff at solo site in project (Ocala II) distributed the questionnaire (Appendix B) to 
all patients checking in for visits with one of the three providers.  The patient was asked to 
complete the questionnaire and then returned it to the provider when once in examination room.  
It was during the visit that the provider reviewed the questionnaire and provided information 
regarding the value of the Tdap vaccination and offered the patient the immunization.  When the 
patient agreed to receive the immunization, the provider then wrote the order for the medical 
assistant to administer once visit is complete.  The medical assistant provided the patient with the 
VIS (Appendix II) information and encouraged them to read the contents.  Once the patient had 
completed reading the VIS (Appendix C) and agreed to administration the medical assistant had 
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the release signed by the patient (Appendix H).  The medical assistant then administered the 
immunization and the patient stayed in office for 15 minutes after administration.  The 
immunization card was provided to the patient to maintain as a permanent record.  In addition 
documentation was made in the patient’s permanent medical record and was entered into the 
state immunization site (Florida Shots).   
Goals/Objectives/Outcomes/Measurable Goals 
     The objective of this program is to increase the administration of the Tdap immunization to 
adults 19 to 64 years of age.  With the increase of adult immunization, there should be a decrease 
in exposure incidence and mortality to infants under twelve months of age.  The measurable goal 
is to increase adult immunization rates of Tdap in adults 19 to 64 years of age to 90 percent in 
this practice.  This goal is established by the CDC and Healthy People 2020 that a minimum of 
90 percent immunization rate is achieved, with current estimates from three percent to 33 percent 
of 19 to 64 years of age currently immunized with Tdap (CDC, 2011).  There is limited 
information with a literature search and contact with Dr. Nathan Grossman (Marion County 
Health Department) related to percentage of Tdaps administered in primary care and the 
percentage of residents 19 to 64 years of age immunized with Tdap.   
      The ARNP provided instructions to the front office to provide every patient over the age of 
19 the questionnaire (Appendix B) to be completed.  The patient then returned the questionnaire 
to the health care provider during visit.  Those patients unsure of vaccination status had their 
immunization status looked up on Florida Shots. The state of Florida requires data input of all 
residents receiving immunizations.  Upon the direction of the provider and agreement of patient 
to receive immunization, the medical assistant administered the Tdap vaccine.  The goal of this 
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project is to increase pertussis immunity in the form of Tdap to 90% per CDC and ATIP 
recommendation.   
     This project was being initiated in one office for eight weeks and results were reported back 
to corporate leaders and the medical directors.  The projected budget is as follows and 
stakeholders/office manager will request weekly accounts receivable from business office to 
ensure budget is maintained:  
 Number of patients 19 to 64 years of age who were assessed for their immunization 
status during four weeks of program for three providers, five days a week was 1010 
patients. 
 This number was a little lower than expected; the ARNP was out one day weekly for 
practicum clinical.  The rest of the clinical practicum hours were after work and on 
weekends to decrease her absence in the office.   
 One of the physicians sees residents at a local long term care facility and is out of office 
one day a week.  This physician also was out for extended weekends two times.   
 The other physician was out for a long weekend, the other weeks he leaves one afternoon 
each week to make rounds at a long term care facility.   
IRB approval and ethical consideration 
     The Family Care Specialist (FCS), site I (OII) employs the project facilitator who is a 
University of Massachusetts Doctor of Nursing Practice (DNP) candidate, a board certified 
Family Nurse Practitioner with over 40 years of nursing experience.  Review of the University of 
Massachusetts Amherst Institution Board (IRB) Guidelines (www.umass.edu/research/). 
concluded that this project falls under the “exempt” category.  IRB is not needed for the 
implementation of the immunization project at FCS (OII) site.  This project is not intended for 
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research; it is an application of knowledge into practice.  This project does not need informed 
consent beyond what patients already provide within the purview of normal patient care by 
primary health care provider.  Data gathered from the implementation of this project will be 
applied for the Nurse Practitioner’s educational requirements in partial fulfillment of the DNP 
degree and actions taken by the NP in the course of this project are governed by the NP’s 
professional license and collaboration agreement with mentor advisor to practice.   
Implementation/Evaluation 
    The stakeholders have approved the project with a letter from the medical director with 
support (appendix VIII) the staff will be given instructions and provided with the project tools to 
complete the immunization administration with proper documentation.  Evaluation and 
effectiveness of the program will be evaluated with meeting the CDC and Healthy People 2020 
goal of 90 percent of population 19 to 64 years of age immunized against Pertussis (CDC, 2011).  
The project will last for eight weeks with the expectation to initiate in the offices locally and 
eventually nationwide in all HCA facilities.   
    The data gathered was the number of patients seen daily by all providers, the number of 
patients that are 19 to 64 years of age, the number of patients who have previously been 
immunized with Tdap, the number of patients who received immunization on date of visit and 
those who have refused.  Analysis was comparing number of patients receiving immunization 
compared to the number of patients seen in office ages 19 to 64 years. 
Figure 2 Timeline:  Immunization of Adults 19-64 years of age with Tdap 
Activity 
                  
Week 
12/15/11 1/3/12 1/4/12 1/17/12 1/25/12 3/16/12 3/29/12 4/3/12 
Importance 
R/T scientific 
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evidence 
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practice 
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daily and 
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Presentation to 
regional 
management 
        
 
     The timeline was constructed after the proposal was approved and accepted by the committee 
for this project.   
 The initial step was to provide information for the stakeholders and members of the team 
that this project is based on scientific evidence.  During the entire project continued 
review of literature and CDC guidelines were continuously reviewed for any changes or 
updates.  
 The second step was to meet with the stakeholders to explain the project, their interest in 
improving healthcare.  This project was presented at a luncheon and the stakeholders 
approved this project.   
 Third step was providing a power point presentation to the staff as they were the major 
link in this project’s success. The office manager, stakeholders and regional manager 
were provided the same information that staff was given. The staff was the initial 
encounter in the office fir the patient and eventually if indicated and agreed to be 
administering the immunization.  Presentation was given at lunch, staff was encouraged 
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to ask questions, all were answered and staff felt they understood the process associated 
with the project.  The staff was encouraged that if any questions they could address them 
immediately and they would receive the answer at the time.   
 Fourth step was the initiation of the project.  The staff began giving out questionnaire to 
the patients being seen by one of the three providers.  The staff at the end of the 
appointment for each patient will place completed questionnaires in ARNP’s office in 
designated space.   
 Fifth step was daily compiling of data and any feedback that was needed to staff 
regarding process, documentation etc.  I placed all data in a secure site on computer with 
using no identifying information if computer is compromised.   
 The sixth step was the presentation to the stakeholders at lunch.   
 The final step is seven and this was a larger presentation to my peers of ARNP’s, two 
DNP’s, two physicians, one medical director, regional manager, and three managers who 
are in charge of the other primary care offices in our local company.   
                                                                  Findings       
     Most companies are concerned with revenue and the cost on their part.  Though no one 
disagrees that immunizations are essential, the medical office must be fiscally responsible to the 
stakeholder.  Table 2 provided an examination of all costs for purchasing, education material, 
and staff costs for Site I, Ocala II.   Medical assistants administered the immunizations once the 
provider wrote the orders.  Their time was approximately 5 minutes to administer and document 
immunization.  There are 4 pieces of paper that were involved in the administration of the 
immunization; VIS, immunization release form that is required by our company, and 
questionnaire.  The next was to purchase the Tdap immunization, which was purchased bi-
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monthly and amount purchased was approved by office manager.  One syringe was used for each 
immunization when administered.  With each immunization administration two needles were 
used one for withdrawing from vial and then the needle was changed prior to administration.  
There are two alcohol swabs used for each immunization administration one to wipe vial prior to 
withdrawing fluid, then one was used to wipe the patient’s site before administration.  We do 
charge for the process of injection.                              
Table 2: Costs/Revenues 
Service # of 
patients 
Cost Unit Total Fee 
charged 
Total Re 
Imburs
ed 
Total 
MA/time 359 $10.00 12 $299.17     
Handouts 359  
        
$13.56 Ream 
500 
page 
$38.94     
Tdap 
purchase 
359 $41.60 One 
vial 
$14,934.40     
Syringe 
purchase 
359 $18.66 Box-
100 
$66.99     
Needle 
purchase 
718 
(2 per 
pt) 
$3.49 Box-
100 
$25.06     
Alcohol 
wipes 
718 
(2 per 
pt) 
$1.29 Box-
200 
$13.03     
Tdap 
immunization 
359  1  $79.30 $28,468.70   
Tdap 
injection 
359  1  $48.57 $3,076.63   
Tdap 
immunization 
359  1    $43.00 $15,437.00 
Tdap 
injection 
359  1    $27.33 $9,811.47 
Total XX XX XX $15,377.59 XX $31,545.33 XX $25,248.47 
  
     Cost evaluation significant to stake holders and corporate board of directors shows a net gain 
of $9,870.88 for 359 patients receiving Tdap in the office.  Receptionist provided the office 
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manager with reports of immunizations report at end of day from computer system when 
balancing A/R.   
Demographics of study participants 
     There were 2,328 patients that had scheduled appointments at OII, with one of the three 
primary healthcare providers who received the questionnaire at time of the appointment for eight 
weeks in 2012.   The target population was those patients seen in medical office at time of visit 
with the healthcare provider.  To obtain the target population Medicare payer patients were 
eliminated, though the CDC states they should also be immunized, their insurance will not pay.  
Of those patients 1,268 were identified for using Medicare as their primary payer source, they 
did not have to be over 65 years of age to utilize this insurance. One provider is Internal 
Medicine with his practice being predominately Medicare based.  Of the remaining 1060 patients 
50 were under the age of 19 years of age leaving a total of 1,010 patients eligible to participate in 
this research translation project.  
     Figure 3 provides the information related to the number of total patients seen in the office 
during the eight week time span.  It looks at the number of Medicare patients seen during the 
same week period and then eventually those 19 years of age and younger were eliminated and 
those patients 19 to 64 years of age who are eligible for participation.  
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 Figure 3: Total of patients seen in office for 8 weeks 
 
Figure 4; Tdap status and administration    
 
     The three categories displayed in Figure 4 incorporate the Tdap immunization and the 
patient’s status during the eight weeks of translation project.  When the patients completed the 
questionnaire, 1010 patients were to be included in project with 293 (29%) had already 
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completed the booster Tdap immunization since the year 2005 when this immunization became 
available and the CDC recommended immunizing 19 to 64 years of age individuals.  Of those 
patients who after talking with the health care provider, 359 (36%) of patients opted to receive 
the Tdap immunization.  A significant finding is the 278 (28%) of the patients still did not want 
to have their immunization updated even after the health care provided discussed it with them at 
time of their visit.     
     Though on the questionnaire we did not ask why the patient declined the immunization on 
that date, we as providers did ask and submitted into our dictation.  The males refused until they 
talked it over with their wives, those were the majority.  Other males stated they do not like 
needles.  Females that refused stated different reasons, but the majority believe that 
immunizations cause illnesses.  Others had not reason and stated they will just think about it.   
     We as providers met at the completion of the eight weeks to discuss how we can make an 
additional impact on those patients who declined the immunization and the results of the project. 
We will be seeking assistance from corporate to put an announcement on our inner office media 
network that the patients see in all our offices while in waiting room.  We will also place a 
reminder in patients chart to revisit at next office visit.  We also will meet monthly to review 
why people decline and address proactively.  We have also decided to change the questionnaire 
to include all adult immunizations.   
Percentage of Tdap Immunization 
     Table 3 and graph 1 provide the percentage of those who had already received their Tdap 
prior to their current visit, those who received their immunization at the time of their visit and 
finally those who declined the immunization and those with no insurance.   The Center for 
Disease Center and Immunization Action Coalition recommend that the goal for immunization 
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be at 90%.  Though we were able to increase the rate of immunization of Tdap from an average 
of 29.5% to 66.4%, it still did not meet the recommendations.   
Table 3: percentage of Tdap immunization      
Current   Given  Total   Declined 
no 
insurance 
Week 1  30 35 65 25 10 
Week 2  31 30 61 31 8 
Week 3  26 41 67 23 10 
Week 4  25 49 74 26 0 
Week 5  38 39 77 23 0 
Week 6  40 34 74 26 0 
Week 7  30 38 68 32 0 
Week 8  21 40 61 32 7 
 
Graph 1; percentage of immunization status 
 
 
Evaluation of Translation Project 
Summary 
     The stated objective for this translation project was to increase the rate of immunity with the 
use of the Tdap immunization for ages 19 to 64 years.  Three healthcare providers participated at 
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Site I, Ocala II which is part of a national corporation with seven local offices.  Each week there 
was administration of Tdap immunizations during the eight weeks of the project. Though there 
were immunizations administrated the increase was unsuccessful to reach the goal of 90% 
recommended by the CDC.    
    The inability to obtain 90% of patients to be immunized per CDC guideline is multi-facet.  
Initially, as providers we had to assess if the patient had insurance and once that was 
accomplished was the need to assess if the insurance would cover administration of Tdap in the 
office and without any puncture wounds.  Those patients on Medicare under the age of 65 do not 
have the coverage unless there is a puncture wound, but even with a puncture wound the 
immunization that must be given is a Tetanus Diphtheria (Td) versus Tdap which has also has 
the component of pertussis.  This alone will always be a deferent to reaching 90%.   
     Secondly, the lack of third party insurance or government assistance is twofold.  Those 
patients without insurance will not take on additional costs during a visit.  They are provided the 
address to the county health department, but most refuse to go there for reasons that are their 
own.  The next is government assistance which we only take Healthease, which is a form of 
Medicaid.  Healthease adults are to go to the health department to receive all immunizations.  
Many of these patients do not have access to transportation.  If they use county transportation 
which costs them $2.00 each way per trip they have to spend hours waiting for pick-up.   
     Finally, part of the group who declined did so because of various reasons.  One of the reasons 
is the same as those parents who decline for their children, fear of side effects that may cause 
long lasting problems.  The next was some of the males wanted to talk to their wives first.  The 
others just did not know at the time of the office visit.   
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     After week four, one of the physicians was gone for a conference for eight working days.  The 
other physician was gone for 5 days during the next four weeks.  There was continued 
administration of Tdap.   
      Those staff members that worked with ARNP with the program demonstrated ownership and 
commitment to their participation with introducing the concept of immunizations to the patient 
as the result of the questionnaire to open the door to questions from the patient. There was 
confirmation from corporate that there was an increase in revenue thus there was no limitation on 
amount of Tdap immunizations that were ordered and maintained in the practice site for project.   
Strengths and Weaknesses of Project 
     There were multiple strengths of this project that provided a cocoon effect of immunity within 
the community.  By increasing the rate of immunizations we increased the rate of pertussis 
immunity.   
     The collaborative cooperation was the main frame produced such positive results.  The 
medical director, regional manager, office manager and internal medicine physician were on 
board from the conception of the translation project. Their support was principal for success, if 
approval from this group was not granted, then the protocol established would not have been 
permitted to proceed.  The majority members of the staff were supportive and verbalized that the 
need for a protocol for Tdap immunization was needed.  Two of the staff members did not have 
the same commitment but they did not have negative results as they were not in direct patient 
care related to the administration of the Tdap immunization.  Use of the questionnaire with 
patient information provided information regarding the immunization and was able to take home 
the information to share.  There were positive results when we received calls from family 
members to receive their Tdap immunization.    
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     Weaknesses of this translation project arose from the inability to create an educational 
component to provide all the information needed without having to wait for months from 
corporate lawyers.  The piece that was written was approved by regional manager as to proceed 
with project.  A larger participation from the other 6 offices would allow a greater look at 
outcomes the regional manager felt it was too much to add to such a busy practice in all seven 
sites...   
     The lack of electronic medical records increases the use of paper, which can be misplaced, the 
medical assistance would not transcribe to the appropriate place in permanent record.  The whole 
process of tracking is dependent on the front office as initial contact of patient to provide 
questionnaire.   
     An additional weakness was the inability to obtain community information from the health 
department director and local hospitals regarding numbers of actual pertussis admissions and the 
percentage of individuals 19 to 4 years of age who have been immunized with Tdap.  The final 
weakness is that those individuals without insurance, who declined to accept the immunization at 
time of appointment due to cost.  They were referred to the health department but they declined 
to use that service, stating they do not like going to the health department.   
Special Recommendations for Project Site 
 Continue to practice by immunizing those patients who are not current.  
 Develop standing orders with the medical director, so if patient is at office for other 
services that the medical assistant can initiate the discussion of immunization 
administration even if the patient is not scheduled to see the healthcare provider.   
 Maintain adequate supplies. 
Special Recommendations for all seven sites in local company 
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 Improve the administration of Tdap immunizations in all seven sites with 28 providers 
participating. 
 Provide patient education material in waiting rooms and examination rooms to explain 
the importance of immunizations.   
 Utilize inner office television system to encourage immunization updates.  
 Collaborate with local primary care healthcare providers and obstetricians and 
gynecologist to provide patient education and increase the rate on administration.  
 Collaborate with local healthcare providers to develop documents for screening of 
patients before appointment to assess status of immunization.  
 Develop local panel of professionals to oversee the project in community.   
 Providing Immunization Schedule to all practices to display in patient areas (Appendix 
H).   
Conclusion 
     The utilization of the questionnaire during the patient’s office visit increased the rate of Tdap 
immunization.  Though we did not obtain the CDC’s goal of 90% of individuals to be 
immunized for Tdap age 19 to 64 years of age, the increase was substantial in developing cocoon 
immunity.  Continued emphasis is placed daily for updating immunization in office.  
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Appendix A; Letter from American Nurses Association 
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Appendix B; Patient Questionnaire 
FAMILY CARE SPECIALISTS 
FRANK FUSCO, MD                     ROBERT KITOS, MD                  DOROTHY COOK, 
ARNP 
Patient Questionnaire for Pertussis Status 
To Our patients, 
     We are seeing an increase in Pertussis (whooping cough) in the United States.  This is a 
highly contagious respiratory disease that affects all ages but with the greatest impact on infants 
under 12 months of age.  Professional organizations and the Centers for Disease Control are 
recommending a booster injection.  We at Family Care Specialists also recommend that you have 
a booster.  Please answer the following questions, and return to your health care provider during 
your visit so we can discuss this with you today.  Thank you for allowing us to be part of your 
team to meet your health care needs.  
PATIENT TO FILL THIS PORTION: 
NAME:  _________________________ __________     Date of Birth:  ______________     
AGE:  ________ 
Have you received the immunization Tdap?      NO _______     YES______ 
                                                                                                      what year: __________ 
Do you have direct or indirect contact with infants less than 12 months?      
                                                                                       NO ________      YES________ 
Do you work or volunteer in health care?  NO ______   YES_______ 
Do you work at the school district or in education?  NO  ______  YES ________ 
Are you employed in law enforcement?    NO _______    YES_________ 
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Are you a grandparent, great grandparent, aunt, uncle or cousin to an infant less than 12 months 
of age?                                                                                    
   YES _________   NO ________ 
 STAFF TO COMPLETE:   
Patient ID#:  _______________________________  
Tdap given today:           YES ________           NO___________ 
Previously given date:   _____________________________ 
Staff signature:  _______________________________________ 
 
RETURN TO DOTTIE AT THE COMPLETION OF THE WORK DAY.  THANK YOU 
FOR YOUR ASSISTANCE 
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Appendix C; Vaccination Immunization Sheet  
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Appendix D; regional structure  
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Manager 1 
wmcormc
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MD ARNP 
REGIONAL STRUCTURE 
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Appendix E; Local structure 
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          MD                
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MA 
MA 
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Check 
in          Insur auth   
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Appendix F; Medical Director Letter of Support 
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IMMUNIZATION CONSENT FORM:  ADULTS 
Immunization Date Manufacture Lot # Expiration 
Date 
Person 
administering 
Patient 
signature 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 
Patient Name:  ____________________________     Patient #:  ____________________ 
Appendix H; Immunization Consent 
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Appendix I:  Adult Immunization Schedule
 
http://www.cdc.gov/vaccines/recs/schedules/downloads/adult/adult-schedule.pdf 
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Appendix J: Thanks 
My thanks to the following people for implementation of Project 
 Frank Fusco, MD, Medical Director 
 Robert Kitos, MD, Internal Medicine 
 Windy Kemp, Market Regional Manager 
 Sandy Manley, Ocala II Office Manager 
 Sharon Lunakis, Check-In  
 Stephanie Jones, Medical Assistant 
 Erika Johnson, Medical Assistant 
 Monique Harris, Medical Assistant 
 Kathy Greathouse, Registered Nurse 
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Author’s Note 
     Journey can defined as traveling from one place to another.  This defines how I have viewed 
my education at University of Massachusetts, Amherst.  There is a piece of structure that I have 
in my purse and I read as I get in the car each day to continue my journey. 
 
 Isaiah 41:10 
      Fear not, for I am with you; be not dismayed, for I am your God; I will strengthen you, I will 
help you, I will uphold you with my righteous right hand.  
 
     I would like to acknowledge those in my life who have been supportive as I completed my 
journey.  The two physicians (Dr. Fusco and Dr. Kitos) who I have the privilege to work with on 
a daily basis who gave me encouragement, Sandy Manley, office manager who was able to break 
through my wall to give me the hugs when I needed one.  To Dr. Myra Sherman, DNP who on 
the other side of the phone provided me the prayers I needed to keep focused.  To Dr. Cynthia 
Jacelon, my chair that provided support and kindness when the paper looked like it would never 
come together.  Finally, my two Australian Shepherds (Charlie Girl and Gracie) for sitting at my 
side and listening to me read my paper, staying up late at night when they wanted so to go to bed.   
 
     My work is dedicated to my grandmother Mary Gray , who I spent wonderful time with when 
I was younger, who with her cancer, I knew I wanted to be a nurse and take care of people.  
 
 
Comments may be addressed to the author at grspcg2009@gmail.com 
